knowing01 GmbH

Startup

knowing01 is a MultiomicsAI TechBio company transforming drug development with a software platform that automatically contextualizes large-scale Multiomics data into decision-ready evidence. With our ‘in silico-first' approach, we de-risk the decisions that shape a program during early-phase discovery and in clinical phases I and II, including those related to targets, indications, mechanisms of action (MoA) and patient stratification, particularly in the fields of oncology, autoimmune and inflammatory diseases and more to come. At the core is the knowing01 App, a MultiomicsAI platform that redefines how Multiomics data is used in the drug development process, complemented by knowing01's analytics services for more robust evidence-based work. Our partners value the investor-ready data stories provided by our analyses, which demonstrate that all appropriate steps have been taken to de-risk any risks.